ANALYST VIEW - Jefferies publishes research on Hungary's Richter

Target price, rating remain unchanged

Richter to pay HUF 63 dividend per share

JP Morgan ups Hungary’s Richter target price

Recommendation raised to overweight

Hungary Richter lowers 2020 sales target

It revises EBIT forecast upwardly, though

Hungary Richter posts record revenue in Q1 2020

Exceeds profit expectations

Hungary Richter expected to report sales close to previous record

First quarter turned out well, according to analysts

Hungary's Richter signs contract manufacturing deal for COVID-19 vaccine

Richter-Helm joint venture to produce Inovio's DNA vaccine

Richter buys antirheumatic drug from Mycenax

In USD 16.5 mn deal

Hungary Richter reveals response to COVID-19 pandemic

Measures introduced to protect employees and to reduce risk of any potential contagion

Hungary Richter to pay HUF 63 dividend per share

According to draft resolutions for general meeting

ANALYST VIEW - Jefferies expects market to 'like' Richter deal

Endorses spending of Vraylar cash

Hungary's Richter adds new product to gynaecological portfolio

For treatment of uterine fibroids and endometriosis

A series of Hungarian firms cancel or postpone general meetings

Including Richter, OTP, Mol

Hungarian fund managers find new top pick

Results of Portfolio's monthly poll are here

Hungary Richter to launch 'wonderdrug' on new market

Company signs exclusive license and supply agreement

EMA accepts new Richter contraceptive

To be sold in Europe and Russia

Richter is a top pick, share price may take off

Management considered overly conservative

Hungary Richter projects moderate revenue growth for 2020

Double-digit increase possible in U.S. and Western Europe

On-offs weigh on the results of Hungary's Richter

Fourth-quarter revenue rises to new record high

Richter Q4 sales seen breaking record

Analysts estimate 10% y/y increase